Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (831-840 of 903) with videos related to

Pageof 91
Sort By:
Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.
British Journal of Cancer|September 1, 2011
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortR Y Zang, P Harter, D S Chi, et al.
Annals of Surgical Oncology|January 9, 2016
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine CancerMario M Leitao, Wazim R Narain, Donna Boccamazzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or lessDennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, et al.
AJNR. American Journal of Neuroradiology|May 9, 2020
MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine GliomaC Jaimes, S Vajapeyam, D Brown, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Elife|September 10, 2020
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapyXin Cui, Chao Ma, Varshini Vasudevaraja, et al.
Gynecologic Oncology|January 9, 2023
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center studyRyan M Kahn, Erin McMinn, Effi Yeoshoua, et al.
Gynecologic Oncology|April 5, 2025
Three-dimensional volumetric rendering on augmented reality headsets for ovarian cancer cytoreduction planning: A Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Kimberly Murphy, Tulsi Patel, et al.
Journal of Neuro-Oncology|November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastomaJayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.
Pageof 91

Showing results (831-840 of 903) with videos related to

Sort By:
Pageof 91
Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.
British Journal of Cancer|September 1, 2011
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortR Y Zang, P Harter, D S Chi, et al.
Annals of Surgical Oncology|January 9, 2016
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine CancerMario M Leitao, Wazim R Narain, Donna Boccamazzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or lessDennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, et al.
AJNR. American Journal of Neuroradiology|May 9, 2020
MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine GliomaC Jaimes, S Vajapeyam, D Brown, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Elife|September 10, 2020
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapyXin Cui, Chao Ma, Varshini Vasudevaraja, et al.
Gynecologic Oncology|January 9, 2023
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center studyRyan M Kahn, Erin McMinn, Effi Yeoshoua, et al.
Gynecologic Oncology|April 5, 2025
Three-dimensional volumetric rendering on augmented reality headsets for ovarian cancer cytoreduction planning: A Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Kimberly Murphy, Tulsi Patel, et al.
Journal of Neuro-Oncology|November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastomaJayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.
Pageof 91